Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with Ga-68-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy




Aida Kiviniemi, Maria Gardberg, Janek Frantzén, Marko Pesola, Ville Vuorinen, Riitta Parkkola, Tuula Tolvanen, Sami Suilamo, Jarkko Johansson, Pauliina Luoto, Jukka Kemppainen, Anne Roivainen, Heikki Minn

PublisherSPRINGER HEIDELBERG

2015

EJNMMI Research

EJNMMI RESEARCH

EJNMMI RES

ARTN 25

5

10

2191-219X

DOIhttps://doi.org/10.1186/s13550-015-0106-2



Conclusions: In HGGs, uptake of Ga-68-DOTA-peptides is associated with disrupted BBB and cannot be predicted by SSTR2 immunohistochemistry. Thus, PET/CT shows limited value to detect HGGs suitable for PRRT. However, high SSTR2 expression portends favorable outcome along with established biomarkers such as IDH1 mutation.




Last updated on 2024-26-11 at 11:06